Ribeiro Ramiro

Chief Medical Officer Ribeiro Ramiro sells entire 42,544-share stake in EYPT for $727,319.46 amid -6.0% revenue decline and $-59.7M annual loss

Ribeiro Ramiro, Chief Medical Officer, liquidated his complete shareholding of 42,544 shares for $727,319.46 on 2026-01-05, leaving him with zero post-transaction holdings. The sale occurs in the context of a company reporting severe financial distress: annual revenue declined 6.0% year-over-year to $966,000.00 in the latest quarter, while net income was $-59,732,000.00 for the most recent full fiscal year. The stock currently trades at $17.37, near the top of its 52-week range of $4.13–$18.85, having appreciated 24.3% over the past 90 days but fallen 2.5% over 30 days. The complete liquidation by a senior medical executive at a historically elevated valuation warrants investor attention to whether this reflects asymmetric information about clinical or operational trajectory.